Medical Properties Trust: The Case For A Turnaround (Archive) Early-stage turnaround as improving fundamentals meet still deeply discounted valuations.
Block: Don't Buy Yet, Wait For Confident Commentary In Q1 (Archive) Tariffs cloud Block’s growth outlook despite Cash App features and healthy Square trends.
Brookfield Asset Management: I Know It Looks Bullish But It's Not A Buy Right Now (Archive) BAM’s improving portfolio and credit growth are offset by fair valuation and technical resistance.
Solid Power: Here's What To Do Now If You Missed Selling Earlier (Archive) Deep-value SLDP faces long commercialization timelines, tightening liquidity, and tariff-driven OEM headwinds.
Morgan Stanley Direct Lending: Why Its Portfolio Is Relatively Insulated Vs. Tariffs (Archive) Tariffs, rate cuts, and recession risks leave MSDL a higher‑risk neutral hold.
Eagle Point Credit: Why I'm Buying The Notes And Preferreds But Avoiding The Common Stock (Archive) Risk-aware CLO credit strategy prioritizing resilient cash flows to safeguard downside.
Enbridge: Get In Now To Enjoy A Multi-Year Bull Run (Archive) Enbridge is poised for outsized, resilient EBITDA growth and a potential multi-year bull run.